Coherus Oncology Inc (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Sales | 460,237 | 527,217 | 538,136 | 631,870 | 553,066 |
| Cost of Goods | 223,421 | 263,358 | 250,561 | 235,222 | 299,196 |
| Gross Profit | 236,816 | 263,859 | 287,575 | 396,648 | 253,870 |
| Operating Expenses | 276,884 | 261,323 | 288,845 | 505,264 | 322,628 |
| Operating Income | -40,068 | 2,536 | -1,270 | -108,616 | -68,758 |
| Interest Expense | 4,822 | 4,485 | 5,020 | 4,795 | 4,862 |
| Other Income | 1,462 | 7,596 | 4,449 | 1,247 | 1,876 |
| Pre-tax Income | -43,428 | 5,647 | -1,841 | -112,164 | -71,744 |
| Income Tax | 4,934 | 664 | 4,720 | 1,829 | -11,858 |
| Net Income Continuous | -48,362 | 4,983 | -6,561 | -113,993 | -59,886 |
| Net Income Discontinuous | 0 | 0 | 0 | 0 | -23,875 |
| Net Income | $-48,362 | $4,983 | $-6,561 | $-113,993 | $-83,761 |
| EBITDA(a) | $-40,068 | $2,536 | $-1,270 | $-108,616 | $-68,758 |